M. Marien

1.1k total citations
24 papers, 769 citations indexed

About

M. Marien is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, M. Marien has authored 24 papers receiving a total of 769 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cellular and Molecular Neuroscience, 9 papers in Molecular Biology and 6 papers in Physiology. Recurrent topics in M. Marien's work include Neuroscience and Neuropharmacology Research (10 papers), Neurotransmitter Receptor Influence on Behavior (7 papers) and Receptor Mechanisms and Signaling (4 papers). M. Marien is often cited by papers focused on Neuroscience and Neuropharmacology Research (10 papers), Neurotransmitter Receptor Influence on Behavior (7 papers) and Receptor Mechanisms and Signaling (4 papers). M. Marien collaborates with scholars based in France, Switzerland and Italy. M. Marien's co-authors include Françis C. Colpaert, C. Anthony Altar, A.‐D. Degryse, A. Lategan, M. Mavridis, J.-C. Martel, Paul L. Wood, Stanley M. Parsons, Philippe Chopin and Agnès L. Auclair and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Neuroscience and Annals of the New York Academy of Sciences.

In The Last Decade

M. Marien

23 papers receiving 749 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Marien France	14	528	296	184	97	87	24	769
Anne E. Fray United Kingdom	8	335 0.6×	210 0.7×	174 0.9×	53 0.5×	105 1.2×	9	589
J. Ułas United States	17	694 1.3×	375 1.3×	128 0.7×	77 0.8×	101 1.2×	21	954
C. Malgouris France	15	660 1.3×	455 1.5×	97 0.5×	66 0.7×	113 1.3×	25	947
Keiko Ikemoto Japan	18	504 1.0×	335 1.1×	125 0.7×	51 0.5×	55 0.6×	63	853
Rosaria Reggio Italy	20	762 1.4×	457 1.5×	247 1.3×	105 1.1×	168 1.9×	32	1.2k
I. Bresink Germany	8	619 1.2×	374 1.3×	94 0.5×	114 1.2×	42 0.5×	11	779
Trevor Dennis France	13	443 0.8×	223 0.8×	86 0.5×	72 0.7×	76 0.9×	20	654
Mauro Federici Italy	19	575 1.1×	379 1.3×	202 1.1×	68 0.7×	87 1.0×	35	922
Silvia Buervenich Sweden	13	430 0.8×	326 1.1×	187 1.0×	181 1.9×	108 1.2×	13	987
Peter‐Andreas Löschmann Germany	12	643 1.2×	244 0.8×	414 2.3×	42 0.4×	69 0.8×	17	897

Countries citing papers authored by M. Marien

Since Specialization

Citations

This map shows the geographic impact of M. Marien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Marien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Marien more than expected).

Fields of papers citing papers by M. Marien

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Marien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Marien. The network helps show where M. Marien may publish in the future.

Co-authorship network of co-authors of M. Marien

This figure shows the co-authorship network connecting the top 25 collaborators of M. Marien. A scholar is included among the top collaborators of M. Marien based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Marien. M. Marien is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Auclair, Agnès L., J.-C. Martel, M.B. Assié, et al.. (2013). Levomilnacipran (F2695), a norepinephrine-preferring SNRI: Profile in vitro and in models of depression and anxiety. Neuropharmacology. 70. 338–347. 84 indexed citations

Debeir, Thomas, M. Marien, Juan E. Ferrario, et al.. (2004). In vivo upregulation of endogenous NGF in the rat brain by the alpha2-adrenoreceptor antagonist dexefaroxan: potential role in the protection of the basalocortical cholinergic system during neurodegeneration. Experimental Neurology. 190(2). 384–395. 19 indexed citations

Bauer, Š., Emmanuel Moyse, F Jourdan, et al.. (2003). Effects of the α2-adrenoreceptor antagonist dexefaroxan on neurogenesis in the olfactory bulb of the adult rat in vivo: selective protection against neuronal death. Neuroscience. 117(2). 281–291. 43 indexed citations

Chopin, Philippe, Thomas Debeir, Rita Raisman‐Vozari, Françis C. Colpaert, & M. Marien. (2003). Protective effect of the α2-adrenoceptor antagonist, dexefaroxan, against spatial memory deficit induced by cortical devascularization in the adult rat. Experimental Neurology. 185(1). 198–200. 8 indexed citations

Debeir, Thomas, M. Marien, Philippe Chopin, et al.. (2002). Protective effects of the α2-adrenoceptor antagonist, dexefaroxan, against degeneration of the basalocortical cholinergic system induced by cortical devascularization in the adult rat. Neuroscience. 115(1). 41–53. 12 indexed citations

Martel, J.-C., Philippe Chopin, Françis C. Colpaert, & M. Marien. (2000). Drug treatments to reduce excitotoxicity in vivo : a potential for α 2 -adrenoceptor antagonists?. Amino Acids. 19(1). 239–252. 3 indexed citations

Cosi, Cristina, Elisabetta Cavalieri, Alessandra Carcereri de Prati, M. Marien, & Hisanori Suzuki. (2000). Effects of kainic acid lesioning on poly(ADP-ribose) polymerase (PARP) activity in the rat striatum in vivo. Amino Acids. 19(1). 229–237. 9 indexed citations

Colpaert, Françis C., et al.. (1999). α2-Adrenoceptor modulation of cortical acetylcholine release in vivo. Neuroscience. 89(4). 1041–1050. 45 indexed citations

Martel, J.-C., Philippe Chopin, Françis C. Colpaert, & M. Marien. (1998). Neuroprotective Effects of the α2-Adrenoceptor Antagonists, (+)-Efaroxan and (±)-Idazoxan, against Quinolinic Acid-Induced Lesions of the Rat Striatum. Experimental Neurology. 154(2). 595–601. 37 indexed citations

10.

Perez, Michel, Petrus J. Pauwels, Philippe Chopin, et al.. (1998). Dimerization of sumatriptan as an efficient way to design a potent, centrally and orally active 5-HT1B agonist. Bioorganic & Medicinal Chemistry Letters. 8(6). 675–680. 27 indexed citations

11.

Cosi, Cristina, Hisanori Suzuki, Stephen D. Skaper, et al.. (1997). Poly(ADP‐Ribose) Polymerase (PARP) Revisited. Annals of the New York Academy of Sciences. 825(1). 366–379. 14 indexed citations

12.

Tacconi, Stefano, Emiliangelo Ratti, M. Marien, G. Gaviraghi, & Norman G. Bowery. (1993). Inhibition of [³H]‐(+)‐MK 801 binding to rat brain sections by CPP and 7‐chlorokynurenic acid: an autoradiographic analysis. British Journal of Pharmacology. 108(3). 577–582. 21 indexed citations

13.

Lategan, A., M. Marien, & Françis C. Colpaert. (1992). EFFECTS OF NORADRENALINE DEPLETION BY DSP4 ON NIGROSTRIATAL AND MESOLIMBIC DOPAMINE RELEASE IN VIVO; A MICRODIALYSIS STUDY. Clinical Neuropharmacology. 15. 601B–601B. 1 indexed citations

14.

Mavridis, M., A.‐D. Degryse, A. Lategan, M. Marien, & Françis C. Colpaert. (1991). Effects of locus coeruleus lesions on parkinsonian signs, striatal dopamine and substantia nigra cell loss after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in monkeys: A possible role for the locus coeruleus in the progression of Parkinson's disease. Neuroscience. 41(2-3). 507–523. 181 indexed citations

15.

Iyengar, Satish, Helen S. Kim, M. Marien, Daniel Mchugh, & Paul L. Wood. (1989). Modulation of mesolimbic dopaminergic projections by beta-endorphin in the rat. Neuropharmacology. 28(2). 123–128. 16 indexed citations

16.

Wood, Patrick B., Hyungmin Kim, D.L. Cheney, et al.. (1988). Constant infusion of [13C6]glucose: Simultaneous measurement of turnover of GABA and glutamate in defined regions of the brain of individual animals. Neuropharmacology. 27(7). 669–676. 19 indexed citations

17.

Altar, C. Anthony & M. Marien. (1987). Picomolar affinity of 125I-SCH 23982 for D1 receptors in brain demonstrated with digital subtraction autoradiography. Journal of Neuroscience. 7(1). 213–222. 92 indexed citations

18.

Marien, M., Richard Gerber, William C. Boyar, & C. Anthony Altar. (1987). Injections of deuterated tryptamine into the nucleus accumbens of the rat: Effects on locomotor activity and monoamine metabolism. Neuropharmacology. 26(10). 1481–1488. 8 indexed citations

19.

Marien, M., Stanley M. Parsons, & C. Anthony Altar. (1987). Quantitative autoradiography of brain binding sites for the vesicular acetylcholine transport blocker 2-(4-phenylpiperidino)cyclohexanol (AH5183).. Proceedings of the National Academy of Sciences. 84(3). 876–880. 59 indexed citations

20.

Brémond, Alain, et al.. (1985). Treatment of vaginitis with benzydamine: preliminary results of a randomized study.. PubMed. 7(3). 225–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact